Martingale Asset Management’s Prothena PRTA Stock Holding History
Bought
Maintained
Sold
Other funds holding PRTA
Martingale Asset Management's PRTA Position: Q3 2026 in Review
Martingale Asset Management increased its Prothena (PRTA) stake by 6.7% in Q3 2026, buying an estimated $47.5K and bringing the position to 84,116 shares worth $705K. The position accounts for 0.02% of the portfolio, ranked #602.
Martingale Asset Management first reported a position in PRTA in Q1 2015 and has held it in 9 quarters since. The position peaked at $1.1M in Q2 2020. 182 funds tracked by Wall St. Rank hold PRTA as of Q3 2026.
- Martingale Asset Management held 84,116 shares of Prothena worth $705K as of Q3 2026.
- Martingale Asset Management bought 5,316 Prothena shares in Q3 2026, an estimated $47.5K.
- Prothena made up 0.02% of Martingale Asset Management's portfolio in Q3 2026, its #602 holding.
- Martingale Asset Management first reported a position in Prothena in Q1 2015 and has held it in 9 quarters since.
- Martingale Asset Management's Prothena position peaked at $1.1M in Q2 2020.
- 182 funds tracked by Wall St. Rank held Prothena as of Q3 2026.
Based on Martingale Asset Management's 13F filing for Q3 2026, filed 12 Nov 2026.